Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks IncfiledCriticalRichardson Vicks Inc
Publication of MX174246BpublicationCriticalpatent/MX174246B/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
La presente invención se refiere a una composición anestesica oral estabilizada caracterizada porque comprende de 0.02 por ciento a 25 por ciento de una sal ácida farmaceuticamente aceptable de una B-amino propiofenona de la fórmula: en donde R1 es un alquilo de C2-C8, R2 y R3 son independientemente alquilo de C1-C6 ó R2 y R3 son (CH2)n en donde n es un número entero de 3 a 7; de aproximadamente 0.02 por ciento a aproximadamente 20 por ciento de sacarina; y de aproximadamente 1 por ciento a aproximadamente 99 de un portador oral farmaceuticamente aceptable.The present invention relates to a stabilized oral anesthetic composition characterized in that it comprises from 0.02 percent to 25 percent of a pharmaceutically acceptable acidic salt of a B-amino propiophenone of the formula: wherein R1 is a C2-C8 alkyl, R2 and R3 are independently C1-C6 alkyl or R2 and R3 are (CH2) n where n is an integer from 3 to 7; from about 0.02 percent to about 20 percent saccharin; and from about 1 percent to about 99 of a pharmaceutically acceptable oral carrier.
Fungicide compositions comprising azolylmethylcyclopentane-benzylidene-derivatives as active ingredient and process for preparation of the active ingredients